Chondromalacia patella is a musculoskeletal pain disorder in which degeneration of cartilage underneath the patella can induce symptoms of pain, stiffness, and crepitus. If left untreated, it can often lead to knee osteoarthritis. Current treatments for chondromalacia patella (physical therapy, NSAIDs, etc.) are often ineffective and sometimes detrimental to the health of the knee. A proposed, alternative treatment currently provided to some patients is Prolotherapy, an injection technique used to stimulate the growth of new cells, including connective tissue.
The sacroiliac joint (SIJ) can become dysfunctional through trauma and/ or pregnancy. The mechanism involves direct or repetitive microtrauma to the buttocks/ lower back. Treatment with specialised physiotherapy alleviates the problems in ~ 80% of cases. The remainder may respond to prolotherapy (hypertonic glucose injections into the dorsal intra-osseous ligament (DIOL) after multiple injections.
Impingement of the medial branch of the superior cluneal (MBSC) nerves are thought to be an overlooked cause of low back pain, with this impingement occurring where the branches of these nerves pass over the superior rim of the iliac crest in osseofibrous tunnels formed by the thoracolumbar fascia.
Osteochondritis concerns the bone located just below the cartilage in general at the level of the femur. A fragment of bone breaks up, the ssure sometimes reaches the cartilage just above it, and at the extreme this osteo-cartilaginous block detaches itself and is released in the joint, posing then the double problem of the presence of a foreign body and an articular lesion. While surgery can, in many cases, treat it, postoperative pain, long rehabilitation and the chance of not returning to sports participation, are reasons to consider Platelet Rich Plasma as an alternative.
Osteochondritis dissecans refers to the separation of osteochondral fragments from the bed of the joint surface. Definition of lesion goes by the existence of an open epiphyseal line in a juvenile form and the absence, representing an adult form. The treatment of osteochondritis dissecans depends on age, on the epiphyseal line, its length, location and stability of the lesion. A conservative treatment is preferred in juvenile cases; a surgical intervention may be necessary for unstable lesions and those not responding to conservative approaches…
Neural prolotherapy, as developed by Jon Lyftogt, has been found to be an effective treatment for neurogenic pain syndromes. We report a case of trigeminal neuralgia successfully treated with neural prolotherapy. The patient is a 70-year-old man with a 15-year history of trigeminal neuralgia refractory to pharmacologic treatment. After one treatment of neural prolotherapy the patient reported 5 months of complete resolution of his symptoms. A second treatment was performed affording him another 10 months of relief. Neural prolotherapy may have an important role in treating trigeminal neuralgia. It can be a safe and effective treatment for those experiencing side effects from medications, contraindications to surgery, or less than favorable improvement from traditional treatments.
With rapid growth of experiences and techniques in the field of Biocellular Regenerative Medicine, clinical scientists and biotechnical advancements constantly seek to understand and optimize uses of the multipotent heterogeneous cellular populations found in adipose tissue complex.
Knee osteoarthritis is an increasing health concern in the adult population. Nonsurgical treatment options for pain reduction and function improvement are limited in number and provide only short-term relief. The potential of regenerative therapies to go beyond temporary symptom reduction and delay or negate the need for total knee joint arthroplasty is enticing to both patients and providers.
Ross A. Hauser, MD1, Danielle R. Steilen, PA-C1 & Paul Fisher2 1Caring Medical Regenerative Medicine Clinics 2Gold Coast Chiropractic ABSTRACT Introduction: Ligamentous injury is widely viewed as a key to the pathophysiology of chronic neck pain. However, this hypothesis has little support with respect to data correlating patient status with either repair-promoting treatments or documentation more »
Avascular necrosis (AVN) of the talus is a debilitating condition, often leading to arthritis and arthrosis of the subtalar and ankle joints. There are three basic categories of cause for AVN. Approximately 10% of AVN of the talus is considered idiopathic: 15% is medication induced and 75% from trauma. The most feared complication of talar injuries is AVN.
Mononeuralgia is pain along the distribution of a single peripheral nerve. Single nerve neuralgia is often caused by compression or other damage to the nerve, although in many cases a specific cause is not apparent. In instances where a structural cause is identified and corrected, patients may continue to experience pain in the affected nerve due to facilitation. This paper will discuss Neural Prolotherapy as a potential treatment for mononeuralgia by demonstrating cases of successful treatments for trigeminal neuralgia and meralgia paresthetica.
Platelet rich plasma (PRP) is under investigation as a therapeutic injectate in a growing number of applications. Its production commonly involves proprietary materials and proprietary centrifuges. Manual PRP production has been described but training efficacy has not been demonstrated. A method to manually produce high quality PRP quickly, inexpensively and consistently, that is easily mastered, would afford the opportunity …
A common malady of the thumb in the carpometacarpal (CMC) joint is osteoarthritis (OA), also known as basal thumb arthritis or trapeziometacarpal (TMC) arthritis. This affliction is often the result of ligament laxity or injury to the thumb, which then creates a cascade of arthritic effects.
The Achilles tendon is the largest and strongest tendon in the human body, and a common site for injury and disease.
By Ross A. Hauser, MD & Marion A. Hauser, MS, RD ABSTRACT The optimal long-term, symptomatic therapy for unresolved knee pain has not been established. Accordingly, we investigated the outcomes of patients undergoing Hackett-Hemwall dextrose Prolotherapy treatment for unresolved knee pain at a charity clinic in rural Illinois. We studied a sample of 80 patients, representing a total of 119 more »
In this clinical case, a 57-year-old white female afflicted with rheumatoid arthritis received treatment for a 35-degree interphalangeal (IP) thumb joint deviation. The thumb deviation clinically described as a boutonniere (French for buttonhole) deformity was treated with a combination of Prolotherapy and splinting. She wore a custom three-point splint for six weeks and received three separate Prolotherapy treatments within that six-week period. After treatment, the deviation decreased from 35 degrees to 10 degrees, and her thumb pain decreased from 7 to 1 on a pain scale of 10 as the highest level.
The scope of practice for the treatment of the ligamentous, capsular and fascial tissues by Manual Therapists (Massage Therapy) limits the therapist to utilizing their hands along with active patient participation.
Pain management and the resolution of that pain has become the campaign of the current veterinary and pet owner communities. The fastest growing segment of our pet population is the aging dog and cat. Prolotherapy is one of the oldest, yet little known, modalities for resolution of pain and lameness. Prolotherapy is compared to its pharmacologic and surgical counterparts. This paper contrasts the current practices available for the resolution of common (ACL) knee injuries and (HD) hip dysplasia in the veterinary community. ACL injuries and HD are the two most prevalent and costly pathologies in modern veterinary practices across America. The science of Prolotherapy is brought into focus and compared with conventional solutions for soft tissue injuries and osteoarthritis. The objective of this paper is to make a case for Prolotherapy and emphasize its usage and application in veterinary medicine.
In the past 10 years, biocellular regenerative medicine has recognized the potential value and availability of a heterogeneous, undifferentiated, nucleated cell population with the adipose tissue complex (ATC). With the recognition of higher mesenchymal stem cell concentrations, ease and safety of access, and the very heterogeneous undifferentiated cell populations in the native 3D adipose matrix, many researchers and clinicians are moving from bone marrow sources to the adipose complex.
By Ross A. Hauser, MD, Havil S. Maddela, BS, Donna Alderman, DO, Gunter Baehnisch, MD, Robert Banner, MD, Peter J. Blakemore, DO, José Eleazar Calderón, MD, Gary B. Clark, MD, Mark DeLaurentis, MD, Shaun Fauley, DVM, Jörn Funck, MD, Babette Gladstein, VMD,Mark L. Johnson, MD, FACS, George H. Kramer, MD, John Neustadt, ND, Joan Resk, DO, JD, José Hector Salazar, MD, Garret Swetlikoff, ND, Rodney S. Van Pelt, MD, & Mark T. Wheaton, MD more »